Impel Pharmaceuticals: Q2 Earnings Insights

Impel Pharmaceuticals IMPL reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Impel Pharmaceuticals missed estimated earnings by 3.81%, reporting an EPS of $-1.09 versus an estimate of $-1.05.

Revenue was up $2.80 million from the same period last year.

Last quarter the company missed on EPS by $0.12 which was followed by a 1.92% increase in the share price the next day.

To track all earnings releases for Impel Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.